Vir Biotechnology, Inc.
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection unde…
Biotechnology
US, San Francisco [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Vir Biotechnology, Inc. (VIR) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology Average | - - | - - | - - | 13,996.25 | 898.20 | 215.93 | 188.58 | 43.57 | 0.00 | 7.5355 | -0.34 | -1.0273 | -23.8425 | -0.09 | -0.10 | 7.0663 | - - | ||
| Maximum | - - | - - | - - | 455,554.00 | 65,349.00 | 25,407.00 | 99,050.00 | 5,305.00 | 0.02 | 701.8537 | 6.70 | 3.0051 | 85.3485 | 0.15 | 8.35 | 61.5621 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -1,175.00 | -56,335.00 | -1,185.00 | 0.00 | -164.8536 | -8.99 | -101.7758 | -1,444.7800 | -1.56 | -12.64 | 0.0007 | - - | ||
| IVERIC bio, Inc. ISEE | 39.95 | 0.15 0.38% | 10,801 vs. 4,945 | 5,512.00 | 0.00 | -70.00 | -50.00 | -937.00 | -0.5200 | -11.8078 | 0.0000 | 0.0000 | 0.0000 | -0.1480 | -0.1151 | 15.2365 | 137.00 | ||
| Madrigal Pharmaceuticals, Inc. MDGL | 317.09 | 2.92 0.93% | 270 vs. 376 | 6,915.00 | 0.00 | -147.00 | -149.00 | -1,483.00 | -7.3800 | -8.6674 | 0.0000 | 0.0000 | 0.0000 | -0.1734 | -0.1363 | 9.2623 | 21.00 | ||
| Akero Therapeutics, Inc. AKRO | 30.64 | -0.40 -1.27% | 428 vs. 551 | 2,138.00 | 0.00 | -53.00 | -35.00 | -627.00 | -0.9000 | -6.6902 | 0.0000 | 0.0000 | 0.0000 | -0.0630 | -0.0585 | 29.8643 | 69.00 | ||
| Karuna Therapeutics, Inc. KRTX | 329.83 | 0.09 0.03% | 1,283 vs. 971 | 12,599.00 | 0.00 | -113.00 | -111.00 | -997.00 | -3.0100 | -26.2644 | 0.0000 | 0.0000 | 0.0000 | -0.0908 | -0.0852 | 18.6075 | 38.00 | ||
| Blueprint Medicines Corporation BPMC | 94.81 | 0.21 0.22% | 543 vs. 620 | 6,022.00 | 96.00 | 89.00 | -102.00 | -2,250.00 | 1.4500 | 16.6530 | 0.0000 | 0.9168 | 0.9274 | 0.2869 | 0.0858 | 3.4266 | 63.00 | ||
| Krystal Biotech, Inc. KRYS | 178.10 | 0.25 0.14% | 180 vs. 225 | 5,122.00 | 45.00 | 0.00 | 14.00 | -268.00 | 0.0300 | 1336.3467 | 0.0000 | 0.9465 | 0.0206 | 0.0012 | 0.0011 | 12.2870 | 28.00 | ||
| Vir Biotechnology, Inc. VIR | 6.74 | -0.19 -2.74% | 1,473 vs. 995 | 928.00 | 56.00 | -65.00 | -111.00 | -303.00 | -0.4800 | -5.2847 | 0.0000 | 0.9188 | -1.1579 | -0.0422 | -0.0364 | 12.4686 | 137.00 | ||
| Reata Pharmaceuticals, Inc. RETA | 172.36 | 0.04 0.02% | 1,909 vs. 954 | 6,566.00 | 22.00 | 192.00 | -70.00 | -1,490.00 | 5.1200 | 5.4820 | 0.0000 | 0.9628 | 8.4849 | 2.2110 | 0.3840 | 2.8209 | 38.00 | ||
| CureVac N.V. CVAC | 2.49 | -0.01 -0.40% | 855 vs. 473 | 558.00 | 12.00 | -70.00 | -101.00 | -1,636.00 | -0.3100 | -2.2038 | 0.0000 | -2.3694 | -5.7022 | -0.1579 | -0.1022 | 2.0371 | 224.00 | ||
| PTC Therapeutics, Inc. PTCT | 41.96 | 2.60 6.61% | 693 vs. 714 | 3,236.00 | 210.00 | -91.00 | 6.00 | -3,375.00 | -1.2000 | -5.9705 | 0.0000 | 0.6846 | -0.4358 | 0.1024 | -0.0512 | 1.8854 | 77.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.